BridgeBio Pharma, Inc. - stock earnings
BBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -168.1 million USD | 1.7 million USD |
| 2023Q3 | -177.0 million USD | 4.1 million USD |
| 2023Q2 | -157.9 million USD | 1.6 million USD |
| 2023Q1 | -176.8 million USD | 1.8 million USD |
| 2022Q4 | -156.0 million USD | 1.9 million USD |
| 2022Q3 | -148.4 million USD | 338000 USD |
| 2022Q2 | 59.4 million USD | 73.7 million USD |
| 2022Q1 | -246.7 million USD | 1.7 million USD |
| 2021Q4 | -147.2 million USD | 12.9 million USD |
| 2021Q3 | -155.9 million USD | 2.3 million USD |
| 2021Q2 | -96.3 million USD | 54.0 million USD |
| 2021Q1 | -163.1 million USD | 462000 USD |
| 2020Q4 | -120.0 million USD | 122000 USD |
| 2020Q3 | -115.9 million USD | 8.1 million USD |
| 2020Q2 | -121.0 million USD | ? USD |
| 2020Q1 | -91.9 million USD | 13.8 million USD |
| 2019Q4 | -73.5 million USD | 13.8 million USD |
| 2019Q3 | -60.0 million USD | 26.7 million USD |
| 2019Q2 | -65.9 million USD | ? USD |
| 2019Q1 | -61.2 million USD | ? USD |
| 2018Q4 | -38.6 million USD | ? USD |
| 2018Q3 | -31.4 million USD | ? USD |
| 2018Q2 | -26.6 million USD | ? USD |
| 2018Q1 | -34.2 million USD | ? USD |
BBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -643.2 million USD | 9.3 million USD |
| 2022 | -494.0 million USD | 77.6 million USD |
| 2021 | -639.3 million USD | 69.7 million USD |
| 2020 | -483.9 million USD | 8.2 million USD |
| 2019 | -260.4 million USD | 40.6 million USD |
| 2018 | -130.7 million USD | ? USD |
| 2017 | -30.6 million USD | ? USD |
BBIO
Price: $24.88
52 week price:
Earnings Per Share: -3.95 USD
P/E Ratio: -8.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Market Capitalization: 5.2 billion